United States was Axcelis Technologies’s largest region in fiscal 2025, bringing in $482.64M of $839.05M (58%).
| Geography | FY 2010 | FY 2013 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $634.08M | $749.29M | $632.03M | $482.64M | ||||||||
| Revenue, Net | — | — | — | — | ||||||||
| Asia Pacific | $246.95M | $335.73M | $347.75M | $306.45M | ||||||||
| Europe | $38.96M | $45.58M | $38.09M | $49.95M | ||||||||
| Total | $920.00M | $1.13B | $1.02B | $839.05M |
Axcelis Technologies brought in $839.05M from its three regions in fiscal 2025, the year ended December 31, 2025. That was down 17.6% from $1.02B in fiscal 2024. United States was the largest at $482.64M (57.5%), ahead of Asia Pacific at $306.45M (36.5%) and Europe at $49.95M (6.0%).
Compared with fiscal 2024, Europe grew fastest, up 31.2% to $49.95M, while United States fell the most, down 23.6% to $482.64M. From fiscal 2022 to 2025, combined revenue from these regions fell from $920.00M to $839.05M, a compound annual decline of 3.0%. United States' share of the total fell from 68.9% to 57.5%.
Product was Axcelis Technologies’s largest product and service line in fiscal 2025, bringing in $792.05M of $854.00M (93%).
| Product and Service | FY 2013 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | — | $1.10B | $976.88M | $792.05M | |||||||
| Ion Implantation Systems & Services | $898.13M | — | — | — | |||||||
| Ion Implantation Systems Services | — | — | — | — | |||||||
| Ion Implantation Systems, Services, & Royalties | — | — | — | — | |||||||
| Services | — | $34.95M | $40.98M | $47.00M | |||||||
| Other Systems & Services | $21.87M | $19.33M | $16.82M | $14.95M | |||||||
| Total | $920.00M | $1.15B | $1.03B | $854.00M |
Axcelis Technologies brought in $854.00M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 17.5% from $1.03B in fiscal 2024. Product was the largest at $792.05M (92.7%), ahead of Services at $47.00M (5.5%) and Other Systems & Services at $14.95M (1.8%).
Compared with fiscal 2024, Services grew 14.7% to $47.00M, while Product fell 18.9% to $792.05M.
Axcelis Technologies stopped reporting Ion Implantation Systems & Services as a separate line after fiscal 2022, when it brought in $898.13M.
Axcelis Technologies (ACLS) reports its revenue by geography and by product and service. In fiscal 2025, United States was its largest region, bringing in $482.64M (57.5% of the total), followed by Asia Pacific at $306.45M (36.5%).
United States was Axcelis Technologies' largest region in fiscal 2025, bringing in $482.64M, or 57.5% of the $839.05M total across its three regions.
Product was Axcelis Technologies' largest product and service line in fiscal 2025, bringing in $792.05M, or 92.7% of the $854.00M total across its three product and service lines.
Among Axcelis Technologies' regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 31.2% from $38.09M to $49.95M.
Every figure comes from Axcelis Technologies' annual financial filings, as reported. Each line keeps the name Axcelis Technologies gives it, and years follow its fiscal calendar.
Axcelis Technologies' revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.